X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Through the acquisition, Navamedic will broaden its product portfolio, including Flexilev, containing two active substances, levodopa and carbidopa and to support patients suffering from medical conditions, such as Parkinson's disease.
Lead Product(s): Etilevodopa,Carbidopa
Therapeutic Area: Neurology Product Name: Flexilev
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Navamedic
Deal Size: $9.3 million Upfront Cash: $9.3 million
Deal Type: Acquisition April 24, 2023
Details:
Through the acquisition, Navamedic will broaden its product portfolio and to support patients suffering from medical conditions, such as Parkinson's disease, including Flexilev, containing two active substances, levodopa and carbidopa.
Lead Product(s): Etilevodopa,Carbidopa
Therapeutic Area: Neurology Product Name: Flexilev
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Navamedic
Deal Size: $7.2 million Upfront Cash: $7.2 million
Deal Type: Acquisition March 29, 2023
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
